Search by Drug Name or NDC

NDC 50742-0431-08 DOCETAXEL 10 mg/mL Details

DOCETAXEL 10 mg/mL

DOCETAXEL is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ingenus Pharmaceuticals, LLC. The primary component is DOCETAXEL ANHYDROUS.

MedlinePlus Drug Summary

Docetaxel injection is used alone or in combination with other medications to treat certain types of breast, lung, prostate, stomach, and head and neck cancers. Docetaxel injection is in a class of medications called taxanes. It works by stopping the growth and spread of cancer cells.

Related Packages: 50742-0431-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Docetaxel Injection

Product Information

NDC	50742-0431
Product ID	50742-431_831c6991-9cc6-48cf-8414-f254746507d8
Associated GPIs	21500005002040
GCN Sequence Number	067167
GCN Sequence Number Description	docetaxel VIAL 80 MG/8 ML INTRAVEN
HIC3	V1F
HIC3 Description	ANTINEOPLASTICS,MISCELLANEOUS
GCN	29662
HICL Sequence Number	010280
HICL Sequence Number Description	DOCETAXEL
Brand/Generic	Generic
Proprietary Name	DOCETAXEL
Proprietary Name Suffix	n/a
Non-Proprietary Name	DOCETAXEL ANHYDROUS
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	10
Active Ingredient Units	mg/mL
Substance Name	DOCETAXEL ANHYDROUS
Labeler Name	Ingenus Pharmaceuticals, LLC
Pharmaceutical Class	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA207563
Listing Certified Through	2024-12-31

Package

NDC 50742-0431-08 (50742043108)

Pricing Information	N/A
NDC Package Code	50742-431-08
Billing NDC	50742043108
Package	1 VIAL, MULTI-DOSE in 1 CARTON (50742-431-08) / 8 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2017-09-07
NDC Exclude Flag	N